Background. Pulmonary resection along with multiple antimicrobial therapy has produced favorable outcomes at a few centers. However, little is known regarding the risk factors for long-term survival and microbiological recurrence after pulmonary resection for nontuberculous mycobacterial pulmonary disease (NTMPD). We evaluated the long-term outcomes of pulmonary resection, including microbiological recurrence and survival.
Nontuberculous mycobacteria (NTM), which include mycobacteria other than Mycobacterium leprae and those in the M. tuberculosis complex, mainly cause pulmonary infection in individuals with structural lung diseases and middle-aged women without preexisting structural lung disease [1] . The incidence of nontuberculous mycobacterial pulmonary disease (NTMPD) is increasing worldwide [2, 3] . In Japan, the most common cause of NTMPD is the Mycobacterium avium complex (MAC), followed by M. kansasii and M. abscessus complex [3] .
With regard to treatment of pulmonary diseases caused by the MAC and M. abscessus complex, although multiple antimicrobial regimens, including macrolides, have advanced in the last decade [1] , their efficacy is often limited to patients with established NTMPD [4, 5] . Furthermore, the recurrence rate of this disease after discontinuation of antimicrobials is high, even upon successful treatment [6, 7] . Thus, as a chronic lung disease, NTMPD affects health-related quality of life and is an important cause of morbidity and mortality [8, 9] .
Previous studies at a limited number of centers in the United States, Korea, and Japan have demonstrated that pulmonary resection in combination with multiple antimicrobial therapy produces favorable outcomes, including high rate of sputum conversion and low postoperative mortality [10] [11] [12] [13] [14] [15] [16] [17] , Other studies have reported high rates of postoperative complications, morbidity, and mortality after pneumonectomy [18, 19] . However, little is known regarding the risk factors for microbiological recurrence and survival after long-term follow-up of patients with NTMPD treated by pulmonary resection. Furthermore, the impact of remnant lesions after pulmonary resection on microbiological recurrence and survival is not clear. This study aimed to evaluate the long-term outcomes of pulmonary resection for NTMPD and to determine the risk factors for microbiological recurrence and survival.
METHODS

Study Design and Patients
This observational, retrospective cohort study included patients with NTMPD treated by pulmonary resection at Minami Yokohama National Hospital or Seirei Yokohama Hospital, Yokohama, Japan, between January 1994 and August 2015. Nontuberculous mycobacterial pulmonary disease was diagnosed in accordance with the 2007 American Thoracic Society (ATS)/Infectious Disease Society of America (IDSA) guidelines [1] . None of the patients had cystic fibrosis, nor did they test positive for human immunodeficiency virus. Only the first instance of pulmonary resection for NTMPD was considered for analysis. With reference to the 1997 ATS official statement and 2007 ATS/IDSA official statement [1, 20] , indications for pulmonary resection were discussed in a multidisciplinary conference including pulmonary physicians and surgeons, on the basis of the following criteria: (1) NTMPD refractory to multiple drug therapy, (2) cavitary lesions and/or severe bronchiectasis, or (3) development of complications such as massive haemoptysis [17] , in addition to adequate predictive postoperative pulmonary function. Although a standard definition for failure of NTMPD treatment has yet to be established, experts define treatment failure as persistent positive sputum culture findings even after 6 months of recommended therapy [21] . Therefore, we carefully selected patients who had received at least 6 months of antimicrobial therapy. In some patients with recurrent NTMPD or a history of NTMPD treatment, we considered surgery before completion of 6 months of antimicrobial therapy as an additional criterion. This study was approved by the institutional review boards of Minami Yokohama National Hospital (No. 20-1) and Seirei Yokohama Hospital (No. 2016-3).
Data Collection
Data including patient age, sex, body mass index (BMI), smoking status, underlying diseases, disease and treatment durations, antimicrobial treatment for NTMPD, results of bacterial culture and pulmonary function test, and chest computed tomography (CT) findings were recorded. Preoperative chest CT images of all patients were acquired within a month before surgery and evaluated by 2 pulmonologists blinded to the clinical data. Post-operative remnant lesions were confirmed by comparing pre-operative CT findings with post-operative visualization of lesions in resected material, as assessed by 3 pulmonary surgeons. Discrepancies were resolved through a consensus review. Nontuberculous mycobacterial species were identified using the AccuProbe (Gen-Probe Inc., San Diego, CA) or COBAS AMPLICOR (Roche Diagnostic Co., Ltd., Tokyo, Japan) systems or by DNA−DNA hybridization assay (Kyokuto Pharmaceutical Industrial Co, Ltd, Tokyo, Japan), as previously described [22] .
Clarithromycin susceptibility for MAC was determined by the broth microdilution method (BrothMIC NTM; Kyokuto Pharmaceutical Industrial Co., Ltd, Tokyo, Japan) [23] , and clarithromycin resistance was defined by minimum inhibitory concentrations ≥32 μg/mL. Data regarding the type of pulmonary resection, operation time, intraoperative blood loss, and postoperative complications and mortality were recorded. Postoperative mortality was defined as death between completion of pulmonary resection and discharge from the hospital.
All patients were followed up until their last visit, death, or the end of study period (August 31, 2015) . Patient status at the end of follow-up was recorded in terms of living status (deceased or alive), microbiological recurrence, and cause of death, if applicable. Sputum conversion was defined as more than 3 consecutive negative sputum cultures over a period of 3 months. Sputum was considered to have converted to smear-negative if patients failed to cough up any sputum [7, 8] even upon sputum induction using hypertonic saline solution. In case of patients who achieved sputum conversion, microbiological recurrence was defined by 2 or more positive sputum cultures regardless of radiological findings [24] . Patients who failed to achieve sputum conversion or died during the perioperative period were excluded from analysis of microbiological recurrence.
Statistical Analyses
Statistical analysis was performed using JMP v11.0 (SAS Institute Japan Ltd, Tokyo, Japan). For univariate analysis, categorical variables were compared by the Fisher's exact test between two groups. Values of P < .05 were considered statistically significant. Survival and microbiological recurrence rates were determined by the Kaplan-Meier method. Differences in survival were analyzed by the log-rank test. Predictive factors for microbiological recurrence and mortality first identified as significant by univariate Cox regression analysis were then evaluated by multivariate Cox regression analysis, in addition to age, sex, and BMI.
RESULTS
Patient Characteristics
During the study period, 125 patients (female, 66 [53%]; male, 59 [47%]) with NTMPD underwent pulmonary resection and were included in this study ( 
Characteristics of Pulmonary Resection and Postoperative Complications
Indications for surgery included poor response to drug therapy (70; 56%), cavitary lesions and severe bronchiectasis (36; 29%), hemoptysis (19; 15%), or a combination of these conditions. No patient died during surgery. Pulmonary resection included pneumonectomy (31; 25%), lobectomy with/without segmentectomy or wedge resection (66; 53%), bilobectomy with/without segmentectomy or wedge resection (12; 10%), segmentectomy with/without wedge resection (13; 10%), or wedge resection (3; 2%) ( Table 2) . Pulmonary resection was mostly performed by thoracotomy (120; 96%); only 5 patients underwent thoracoscopy (wedge resection, 3; lobectomy, 2). Only 3 patients-who had diabetes mellitus and underwent right pneumonectomy-received muscle flaps following surgery. The median operation time and volume of blood loss were 128 min (IQR, 103-183 min) 
Mycobacterium species
Mycobacterium avium 100 (80)
Mycobacterium intracellulare 10 (8)
Mycobacterium abscessus complex 6 (5)
Mycobacterium kansasii 4 (3)
Mycobacterium gordonae 2 (2)
Mycobacterium chelonae 1 (1)
Mycobacterium fortuitum 1 (1)
Mycobacterium xenopi 1 (1) Pre-and postsurgical treatment Bronchopulmonary fistula (7; 6%) was the most frequent postoperative complication, followed by empyema (6; 5%), exacerbation of interstitial lung disease (2; 2%), bronchopleural fistula (2; 2%), and pneumonia (2; 2%). Other complications included bronchial stenosis, diaphragmatic hernia, gastric ulcer, intrapleural hemorrhage, left atrium rupture, prolonged air leak, and wound dehiscence (1, each; 1%). Postoperative mortality was 3%-4 patients who received pneumonectomy died before being discharged from the hospital (pneumonia, 2; rupture of the left atrium, 1; empyema due to methicillin-resistant Staphylococcus aureus, 1).
Pre-and Postsurgical Radiological Features of Remnant Lesions
Presurgical remnant lesions included nodules (122; 98%), cavities (87; 70%), bronchiectasis (111; 89%), and destructive lesions (30; 24%; Table 3 ). After pulmonary resection, 16 (13%) and 3 (2%) patients exhibited remnant cavitary and destructive lesions, whereas 74 (59%) and 64 (51%) patients exhibited nodules and bronchiectasis. The numbers of affected lobes in the lungs before and after pulmonary resection were 3 (IQR, 2-5) and 1 (IQR, 1-3), respectively.
Incidence and Predictive Factors of Microbiological Recurrence After Pulmonary Resection
The data of 11 patients were excluded from analysis of microbiological recurrence; 4 of these patients had died before discharge, whereas 7 failed to achieve sputum conversion. Thus, 114 patients (91%) who had achieved sputum conversion were included in this analysis. The median follow-up duration of the 114 patients was 5.8 years (IQR, 2.9-9.1 years). The cumulative recurrence rates at 1, 3, 5, and 10 years after surgery were 4.6%, 10%, 15%, and 20%, respectively (Figure 1 (24) 64 (51) 25 (20) 23 (18) 19 (15) 9 (7) 19 (15) 10 (8) Destructive lesion 30 (24) 15 (12) 2 (2) 6 (5) 12 (10) 9 (7) 9 (7) 3 (2) 2 ( 
Figure 1.
Cumulative rate of microbiological recurrence after pulmonary resection in patients with nontuberculous mycobacterium pulmonary disease according to the Kaplan-Meier method. Cumulative recurrence rates at 1, 3, 5, and 10 years after surgery were 4.6%, 10%, 15%, and 20%, respectively.
Predictive Factors for Prognosis and Survival After Pulmonary Resection
The median follow-up duration of the 125 patients was 7.1 years (IQR, 3.5-10.3 years). The survival rates at 1, 3, 5, and 10 years after surgery were 94%, 90%, 84%, and 76%, respectively (Figure 2 ). At the end of follow-up, 26 patients had died. Of the 7 patients who failed to achieve sputum conversion, 5 had died. Two patients with clarithromycin-resistant MAC died at 21 and 48 months post-surgery. The differences in survival rate among the different species of NTM were not statistically significant. The results of univariate and multivariate Cox regression analyses of factors related to survival are presented in Table 5 The causes of death in the 26 patients who died during the study period included pneumonia (n = 10), progression of NTMPD (n = 3), congestive heart failure (n = 2), empyema (n = 2), nephropathy (n = 1), bowel cancer (n = 1), Abbreviations: aHR, adjusted hazard ratio; CI, confidence interval; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; MAC, Mycobacterium avium complex; NTM, nontuberculous mycobacteria; TB, tuberculosis. a Of the 125 patients included in the study, 11 were excluded from analysis of microbiological recurrence-4 died during the perioperative period, and 7 did not achieve sputum conversion. Kaplan-Meier survival curves of patients after pulmonary resection for nontuberculous mycobacterium pulmonary disease. Survival rates at 1, 3, 5, and 10 years after surgery were 94%, 90%, 84%, and 76%, respectively.
pneumothorax (n = 1), left atrial rupture (n = 1), and unknown reasons (n = 5).
DISCUSSION
In the present study, we determined the long-term outcomes and factors associated with microbiological recurrence and survival after pulmonary resection in patients with NTMPD. Approximately 90% of the included patients achieved sputum conversion, and the rates of postoperative complications after pneumonectomy and other types of pulmonary resection were 42% and 15%, respectively. These results correspond with those of previous studies involving patients treated by pneumonectomy [19, 25] or other types of pulmonary resection [14, 16, 17] . The present study produced 3 significant findings. First, pneumonectomy is a negative prognostic factor for survival after pulmonary resection. Despite the low incidence of microbiological recurrence following pneumonectomy, the procedure has a high rate of postoperative complications. Second, presence of remnant cavitary lesions after pulmonary resection is a predictive factor for both microbiological recurrence and poor prognosis. Finally, old age and low BMI are associated with poor prognosis after pulmonary resection for NTMPD. Previous studies on various pulmonary diseases have reported pneumonectomy to be associated with high rates of postoperative complications and poor survival after pulmonary resection. In a study involving 115 patients who underwent pneumonectomy for benign disease and lung cancer, the mortality rates were reported to be 26.3% and 17.6%, respectively [26] . Additionally, a meta-analysis of studies on multidrug-resistant (MDR)-tuberculosis-which shares many clinical features with NTMPD, including poor treatment response and limited options for antimycobacterial medication-revealed that partial lung resection, but not pneumonectomy, resulted in treatment success among patients with MDR-tuberculosis [27] . Two other studies have reported high postoperative mortality and morbidity rates specifically in patients with NTMPD treated by pneumonectomy. In a Japanese study involving 11 patients who underwent pneumonectomy for NTMPD, 4 patients (36%) experienced postoperative complications; although 2 patients (18%) died within the median follow-up duration of 2 years [19] , all patients had achieved sputum conversion, with only 1 patient experiencing relapse/reinfection. In a study involving 26 patients (NTMPD, 21; M. tuberculosis infection, 5) who underwent pneumonectomy at a single center in the United States, 12 patients (46%) experienced a total of 27 postoperative complications, and 6 (23%) died during initial hospitalization [25] . In the present study, of the patients who underwent pneumonectomy, 16 (62%) died within 6 years of surgery, whereas the surviving patients exhibited a low rate of microbiological recurrence. Although the procedure might have resolved NTMPD in a few of these patients, our findings do not clarify the criteria for selection of patients who might benefit from pneumonectomy. To our knowledge, the present study is the first to demonstrate that the presence of remnant cavitary lesions after pulmonary resection not only affects microbiological recurrence but is also predictive of poor prognosis over long-term follow-up. In case of advanced NTMPD, cavities with extensive bronchiectasis are formed as a result of drainage of parenchymal caseous necrosis from the connected bronchus [28, 29] . Previous observational studies that did not involve pulmonary resection have reported cavitary lesions to be predictive factors for poor prognosis as well as disease progression and relapse/reinfection after discontinuation of antimicrobial therapy [30] [31] [32] . Accordingly, presence of cavities has been considered as one of the main indications for pulmonary resection, with presence of remnant cavitary lesions being considered to result in poor prognosis. In the present study, surgical indication and duration of antimicrobial therapy were carefully determined on the basis of presence of remnant cavitary lesions after pulmonary resection.
Age and BMI have also been reported as poor prognostic factors in patients with NTMPD [9, 33] . With regard to pulmonary surgery, low BMI and older age were reported to be predictors of mortality or morbidity in 27 844 patients with lung cancer [34] . Although no study to date has investigated the relationship between BMI and pulmonary resection for NTMPD, low BMI has been reported to be associated with poor outcome in patients with MDR and extensively drug-resistant tuberculosis undergoing surgical therapy [35] . Taken together, these findings indicate that BMI should be assessed as an indicator of disease severity prior to pulmonary resection.
The present study has several limitations. First, because of the retrospective study design, we could not exclude potential confounding factors such as microbiological and other laboratory data. Although the combination of aminoglycoside and surgery for macrolide-resistant MAC pulmonary disease resulted in a good treatment outcome [36] , the available data in the study were limited. Second, shorter duration of antimicrobial therapy might affect the clinical outcome. Although the optimal duration of antimicrobial therapy after pulmonary resection is unclear, experts have recently recommended a treatment duration of more than 12 months [17, 37] . Because we included patients from 1994, when the optimal treatment duration was poorly understood, the treatment duration in this study was shorter than that recommended by experts. Third, patients for surgery were only selected from two referral centers, both with experience in surgical management of NTMPD, which might have led to beneficial selection bias. This also indicates the importance of surgical expertise for ensuring favorable outcomes in pulmonary resection for NTMPD. Finally, we did not evaluate the factors affecting the decision-making by the pulmonary physicians and surgeons with regard to the timing and type of pulmonary resection and antimicrobial therapy. Although these factors might have resulted in bias, our findings correspond with those of previous studies in terms of perioperative morbidity and mortality, which suggests that our practice did not deviate from standard management practices. Additionally, we were able to identify significant factors associated with microbiological recurrence and survival after pulmonary resection after long-term follow-up. Given that these factors are associated with advanced NTMPD, surgery should be considered earlier, especially in case of patients with drug-resistant NTMPD. Moreover, surgical resection with antimicrobial therapy has been demonstrated to provide better clinical outcomes in patients with M. abscessus complex infections and clarithromycin-resistant MAC pulmonary disease [17, 36, 38, 39] . To determine the optimal timing of surgery and identify the criteria for selection of patients who might benefit from surgery, prospective multicenter cohort or randomized control studies for comparative evaluation of chemotherapy with and without pulmonary resection, with consideration of microbiological and other laboratory data, are required, especially in patients who do not require pneumonectomy. Furthermore, prospective observational studies are required to identify patients who could benefit from pneumonectomy.
In conclusion, this study has identified significant predictive factors for long-term microbiological recurrence and survival in patients with NTMPD treated by pulmonary resection. Pneumonectomy, remnant cavitary lesions, older age, and low BMI are negative prognostic factors. Additionally, remnant cavitary lesions are predictive of microbiological recurrence. Pneumonectomy significantly decreases the risk of microbiological recurrence despite its high rates of morbidity and mortality. Patients who could benefit from pulmonary resection should be carefully selected with consideration for age, BMI, remnant lesions after surgery, and type of pulmonary resection.
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